| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ole Havndrup, Michael Christiansen, Birgitte Stoevring, Morten Jensen, Jakob Hoffman-Bang, Paal Skytt Andersen, Lis Hasholt, Anne Nørremølle, Ulla Feldt-Rasmussen, Lars Køber, Henning Bundgaar. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. European journal of heart failure. vol 12. issue 6. 2010-08-20. PMID:20498269. |
fabry disease, an x-linked storage disorder caused by defective lysosomal enzyme alpha-galactosidase a activity, may resemble sarcomere-gene-associated hypertrophic cardiomyopathy (hcm). |
2010-08-20 |
2023-08-12 |
Not clear |
| G E Linthorst, M G Bouwman, F A Wijburg, J M F G Aerts, B J H M Poorthuis, C E M Holla. Screening for Fabry disease in high-risk populations: a systematic review. Journal of medical genetics. vol 47. issue 4. 2010-07-28. PMID:19797197. |
fabry disease (fd) may present with left ventricular hypertrophy (lvh), renal insufficiency or stroke. |
2010-07-28 |
2023-08-12 |
Not clear |
| He-jun Liu, Ke-jiang Cao, Cheng-rang Li, Jian Dai, Ji-zheng Ma, Yong-hong Yong, Wei Su. [Alpha-galactosidase A gene mutation in a Chinese family with Fabry disease mimicking clinical features of hypertrophic cardiomyopathy]. Zhonghua xin xue guan bing za zhi. vol 34. issue 2. 2009-07-07. PMID:16626582. |
[alpha-galactosidase a gene mutation in a chinese family with fabry disease mimicking clinical features of hypertrophic cardiomyopathy]. |
2009-07-07 |
2023-08-12 |
Not clear |
| He-jun Liu, Ke-jiang Cao, Cheng-rang Li, Jian Dai, Ji-zheng Ma, Yong-hong Yong, Wei Su. [Alpha-galactosidase A gene mutation in a Chinese family with Fabry disease mimicking clinical features of hypertrophic cardiomyopathy]. Zhonghua xin xue guan bing za zhi. vol 34. issue 2. 2009-07-07. PMID:16626582. |
to screen gene mutation in alpha-galactosidase a (alpha-gal a) in a nonconsanguineous chinese family with fabry disease (fd) with clinical manifestations similar to hypertrophic cardiomyopathy (hcm). |
2009-07-07 |
2023-08-12 |
Not clear |
| Juha W Koskenvuo, Erik Engblom, Ilkka M Kantola, Jaakko J Hartiala, Antti Saraste, Tuomas O Kiviniemi, Ilkka Mononen, Markku Sarast. Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance. Clinical physiology and functional imaging. vol 29. issue 3. 2009-05-28. PMID:19320660. |
it has been suggested that this sign could be used with good accuracy to differentiate fabry disease from hypertrophic cardiomyopathy and even as a first filter to screen for suspected fabry disease. |
2009-05-28 |
2023-08-12 |
Not clear |
| Frank Weidemann, Markus Niemann, Frank Breunig, Sebastian Herrmann, Meinrad Beer, Stefan Störk, Wolfram Voelker, Georg Ertl, Christoph Wanner, Jörg Strotman. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. vol 119. issue 4. 2009-03-04. PMID:19153271. |
enzyme replacement therapy with recombinant alpha-galactosidase a reduces left ventricular hypertrophy and improves regional myocardial function in patients with fabry disease during short-term treatment. |
2009-03-04 |
2023-08-12 |
Not clear |
| Michael Teitcher, Sarah Weinerman, Catharina Whybra, Michael Beck, Nir Sharon, Deborah Elstein, Gheona Altaresc. Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease. Genetica. vol 134. issue 3. 2008-11-18. PMID:18278558. |
fabry disease, an x-linked inborn error of metabolism, is characterized by multi-organ involvement including cardiac signs of left ventricular hypertrophy and abnormal intima-medial (imt) thickening of arteries, progressive renal failure, neurological involvement, and more. |
2008-11-18 |
2023-08-12 |
Not clear |
| Andrea K Rutz, Christoph F Juli, Salome Ryf, Urs Widmer, Sebastian Kozerke, Boris P Eckhardt, Peter Boesige. Altered myocardial motion pattern in Fabry patients assessed with CMR-tagging. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. vol 9. issue 6. 2008-02-25. PMID:18066749. |
progressive left ventricular hypertrophy is the hallmark of cardiac manifestations in patients with fabry disease. |
2008-02-25 |
2023-08-12 |
human |
| Lorenzo Monserrat, Juan Ramón Gimeno-Blanes, Francisco Marín, Manuel Hermida-Prieto, Antonio García-Honrubia, Inmaculada Pérez, Xusto Fernández, Rosario de Nicolas, Gonzalo de la Morena, Eduardo Payá, Jordi Yagüe, Jesús Egid. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology. vol 50. issue 25. 2008-01-07. PMID:18154965. |
prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. |
2008-01-07 |
2023-08-12 |
Not clear |
| Lorenzo Monserrat, Juan Ramón Gimeno-Blanes, Francisco Marín, Manuel Hermida-Prieto, Antonio García-Honrubia, Inmaculada Pérez, Xusto Fernández, Rosario de Nicolas, Gonzalo de la Morena, Eduardo Payá, Jordi Yagüe, Jesús Egid. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology. vol 50. issue 25. 2008-01-07. PMID:18154965. |
we aimed to study the prevalence of fabry disease (fd) in patients with hypertrophic cardiomyopathy (hcm). |
2008-01-07 |
2023-08-12 |
Not clear |
| Michael J Ackerman, Andrew P Landstro. Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy. Journal of the American College of Cardiology. vol 50. issue 25. 2008-01-07. PMID:18154966. |
detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy. |
2008-01-07 |
2023-08-12 |
Not clear |
| Norman Sadick, Liza Thoma. Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study. Heart, lung & circulation. vol 16. issue 3. 2007-08-10. PMID:17452128. |
fabry disease should be considered in the differential diagnosis in patients with unexplained lvh and late onset hypertrophic cardiomyopathy. |
2007-08-10 |
2023-08-12 |
human |
| Ph Hoigné, C H Attenhofer Jost, F Duru, E N Oechslin, B Seifert, U Widmer, B Frischknecht, R Jenn. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. International journal of cardiology. vol 111. issue 3. 2007-01-03. PMID:16307805. |
simple criteria for differentiation of fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. |
2007-01-03 |
2023-08-12 |
Not clear |
| Ph Hoigné, C H Attenhofer Jost, F Duru, E N Oechslin, B Seifert, U Widmer, B Frischknecht, R Jenn. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. International journal of cardiology. vol 111. issue 3. 2007-01-03. PMID:16307805. |
fabry disease may be difficult to differentiate from other causes of left ventricular hypertrophy such as other myocardial storage diseases (including amyloidosis), hypertrophic cardiomyopathy (hcm), or hypertensive heart disease (hhd). |
2007-01-03 |
2023-08-12 |
Not clear |
| Frédéric Barbey, Noureddine Brakch, Ales Linhart, Nathalie Rosenblatt-Velin, Xavier Jeanrenaud, Salah Qanadli, Beat Steinmann, Michel Burnier, Tomas Palecek, Jan Bultas, Daniel Hayo. Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arteriosclerosis, thrombosis, and vascular biology. vol 26. issue 4. 2006-07-14. PMID:16469946. |
cardiac and vascular hypertrophy in fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. |
2006-07-14 |
2023-08-12 |
mouse |
| Christopher L Owens, Stuart D Russell, Marc K Halushk. Histologic and electron microscopy findings in myocardium of treated Fabry disease. Human pathology. vol 37. issue 6. 2006-07-10. PMID:16733219. |
the well-described histologic and electron microscopic findings in fabry disease cardiomyopathy are hypertrophic vacuolated cells with electron dense concentric lamellar bodies. |
2006-07-10 |
2023-08-12 |
Not clear |
| Hiroshi Hasegawa, Hiroyuki Takano, Satoshi Shindo, Shinichi Takeda, Nobusada Funabashi, Keiichi Nakagawa, Tetsuya Toyozaki, Yoichi Kuwabara, Issei Komur. Images in cardiovascular medicine. Transition from left ventricular hypertrophy to massive fibrosis in the cardiac variant of Fabry disease. Circulation. vol 113. issue 16. 2006-05-04. PMID:16636179. |
transition from left ventricular hypertrophy to massive fibrosis in the cardiac variant of fabry disease. |
2006-05-04 |
2023-08-12 |
Not clear |
| Liza Thomas, Norman Sadic. A case of Fabry disease mimicking hypertrophic cardiomyopathy. Heart, lung & circulation. vol 13. issue 2. 2006-01-12. PMID:16352193. |
a case of fabry disease mimicking hypertrophic cardiomyopathy. |
2006-01-12 |
2023-08-12 |
Not clear |
| J Strotmann, F Weidemann, F Breunig, A Knoll, C Wanner, G Ert. Morbus Fabry of the heart. Why should cardiologists care? Zeitschrift fur Kardiologie. vol 94. issue 9. 2005-12-07. PMID:16142514. |
this implied the hypothesis that some of those patients with unexplained myocardial hypertrophy do suffer from fabry disease. |
2005-12-07 |
2023-08-12 |
Not clear |
| Sudheera Magage, Ales Linhart, Jan Bultas, Jan Vojacek, Martin Mates, Tomas Palecek, Jana Popelová, Jaroslav Tintera, Michael Aschermann, Martin E Goldman, Robert J Desnic. Fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male. Echocardiography (Mount Kisco, N.Y.). vol 22. issue 4. 2005-09-01. PMID:15839990. |
fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male. |
2005-09-01 |
2023-08-12 |
Not clear |